News
The pilot study in north-east England will pioneer a personalised medicine approach.
Investors have showered the New York company with $876 million to date.
The companies expect the deal to close in the second quarter of 2021, subject to customary closing conditions.
The telehealth brand's annual revenue increased 80% YoY to $148.8 million in 2020, although its quarterly YoY growth dipped in Q4 compared to the months prior.
OMERS Growth Equity and Kaiser Permanente Group Trust led the round, with participation from McKesson Ventures and B Capital Group.
The company said that its platform is tracking more than 325 million patients' healthcare encounters.
The digital cardiology platform is designed to give patients a comprehensive, equitable and accessible way to manage hypertension and heart disease.
The SEC has charged uBiome cofounders with defrauding investors and pushing doctors to order unnecessary medical tests.
The keynote presenter at HIMSS’ Accelerate Health event shares his game plan for how stakeholders can use big data to improve the quality, safety and effectiveness of drug therapies.
Providers must go beyond just learning about a patient's SDOH to change the game; they must also support changes.